Advertisement

About PCROWD, Dana-Farber’s Tissue-Banking Study for Patients with Myeloproliferative Neoplasms, Smoldering Multiple Myeloma, Smoldering Waldenstrom’s Macroglobulemia, and Early Myelodysplastic Syndromes

PCROWD is a project of the Center for Prevention of Progression of Blood Cancers (CPOP), a research initiative at Dana-Farber Cancer Institute focused on understanding the progression and clonal evolution of blood cancers – with the ultimate aim of developing targeted therapeutic agents that can eliminate the early clones of disease.

 Cancer Connect